J Allergy Clin Immunol:慢性鼻窦炎生命早期风险因素研究

2018-02-14 AlexYang MedSci原创

慢性鼻窦炎在那些表现为晚期疾病和鼻窦粘膜发生不可逆变化的成年人中经常被诊断到。理解慢性鼻窦炎的自然历史对开发出预防或者减缓该疾病进展的治疗方法非常重要。最近,有研究人员在一个纵向群体研究中确定了生命早期风险因素。研究包括了4中表型的小组:没有鼻窦炎(n=621)、只有儿时短暂性鼻窦炎(n=57)、晚发性成年鼻窦炎(n=68)和早发性慢性鼻窦炎(儿童和成年鼻窦炎,n=26)。研究发现,在10.8%的

慢性鼻窦炎在那些表现为晚期疾病和鼻窦粘膜发生不可逆变化的成年人中经常被诊断到。理解慢性鼻窦炎的自然历史对开发出预防或者减缓该疾病进展的治疗方法非常重要。最近,有研究人员在一个纵向群体研究中确定了生命早期风险因素。

研究包括了4中表型的小组:没有鼻窦炎(n=621)、只有儿时短暂性鼻窦炎(n=57)、晚发性成年鼻窦炎(n=68)和早发性慢性鼻窦炎(儿童和成年鼻窦炎,n=26)。研究发现,在10.8%的儿童和12.2%的成年人中发现了鼻窦炎。儿童时期鼻窦炎是成年鼻窦炎最强烈的独立风险因子(OR=4.2, 95%CI:2.5, 7.1, p<0.0001, n=772)。早发性慢性鼻窦炎与9个月大的增加的血清lgE水平相关,还与特异性反应(皮刺试验反应评估)、儿童湿疹和过敏性鼻炎、童年经常感冒、母亲哮喘以及并发的哮喘流行度的增加相关。另外,在晚发性成年鼻窦炎和生命早期风险因素之前,研究人员并没有发现相关性。

最后,研究人员指出,他们鉴定了一个早发性慢性鼻窦炎表型,且与生命早期易被病毒感染/感冒体质、过敏和哮喘相关。对该机制的分子机制解析也许能够在未来阻止该疾病发展到成年鼻窦炎。

原始出处: 

Chang EH, Stern DA, Willis AL et al. Early life risk factors for chronic sinusitis: a longitudinal birth cohort study. J Allergy Clin Immunol. 17 Jan 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=292952, encodeId=e3c1292952d3, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Mar 04 15:18:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288672, encodeId=03162886e299, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Feb 17 11:29:47 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288662, encodeId=07a2288662f1, content=^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sat Feb 17 10:48:11 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329083, encodeId=599d1329083a7, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351383, encodeId=dfe51351383b7, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-03-04 1e145228m78(暂无匿称)

    学习了.谢谢作者分享!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=292952, encodeId=e3c1292952d3, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Mar 04 15:18:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288672, encodeId=03162886e299, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Feb 17 11:29:47 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288662, encodeId=07a2288662f1, content=^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sat Feb 17 10:48:11 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329083, encodeId=599d1329083a7, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351383, encodeId=dfe51351383b7, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-17 王秀

    学习了.涨知识了!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=292952, encodeId=e3c1292952d3, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Mar 04 15:18:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288672, encodeId=03162886e299, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Feb 17 11:29:47 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288662, encodeId=07a2288662f1, content=^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sat Feb 17 10:48:11 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329083, encodeId=599d1329083a7, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351383, encodeId=dfe51351383b7, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-17 wqkm

    ^_^^_^^_^^_^

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=292952, encodeId=e3c1292952d3, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Mar 04 15:18:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288672, encodeId=03162886e299, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Feb 17 11:29:47 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288662, encodeId=07a2288662f1, content=^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sat Feb 17 10:48:11 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329083, encodeId=599d1329083a7, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351383, encodeId=dfe51351383b7, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-16 膀胱癌
  5. [GetPortalCommentsPageByObjectIdResponse(id=292952, encodeId=e3c1292952d3, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Mar 04 15:18:06 CST 2018, time=2018-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288672, encodeId=03162886e299, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Feb 17 11:29:47 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288662, encodeId=07a2288662f1, content=^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sat Feb 17 10:48:11 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329083, encodeId=599d1329083a7, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351383, encodeId=dfe51351383b7, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 16 09:02:00 CST 2018, time=2018-02-16, status=1, ipAttribution=)]

相关资讯

Ann Allergy Asthma Immunol: 非裔美国人慢性鼻窦炎的阻塞性睡眠呼吸暂停风险

大家都比较熟悉的是患有慢性鼻窦炎(CRS)的病人通常会经历睡眠困扰。其中的许多病人具有阻塞性睡眠呼吸暂停(OSA)相关诊断结果。然而,CRS群体中发展成为OSA的风险因子仍旧所知很少。最近,研究人员就鉴定CRS中OSA的风险因子进行了调查,并指出哪些患有CRS的病人应该去筛查OSA。研究将一个大的并确诊为CRS的患者群体作为研究群体进行评估。研究人员对病人的医疗记录进行了回顾来鉴定那些通过整夜睡眠

J Laryngol Otol:季节性变态反应是急性鼻窦炎的风险因子吗?

最近,有研究人员在患有草花粉诱导的鼻炎儿童中,评估了花粉季节急性鼻窦炎的发生情况。研究人员选择了那些具有草花粉诱导的鼻子症状但是没有鼻窦炎症状的儿童作为研究群体,并且询问了他们的父母,并且完成了在花粉接触期间的记录,主要是报道日常的鼻子症状和药物使用。当怀疑后鼻窦炎时,研究人员利用纤维内窥镜检查法对急性鼻窦炎急性确诊。那些没有吸入剂过敏的儿童作为研究的对照。研究发现,242名儿童的17名(7.0%

Int Forum Allergy Rhinol:空气污染物也许是慢性鼻窦炎疾病发展的一个环境风险因素

关于环境暴露在慢性鼻窦炎(CRS)病理过程中的角色到目前为止所知甚少。最近,有研究人员测量了空气污染物对患有鼻息肉的CRS(CRSwNP)和不患有鼻息肉的CRS(CRSsNP)病人的影响。研究总共包括了234名病人,其中CRSsNP有138名,CRSwNP有96名。研究人员还利用了来自污染物检测站点的空间模型来评估周围环境的接触,从而来选择能够满足入选标准的病人。研究发现,平均PM2.5和BC在C

J Allergy Clin Immunol Pract:非变应性鼻炎儿童的复发急性鼻窦炎的阿奇霉素预防

复发性急性鼻窦炎(RARS)是通过急性鼻窦炎的多种发作情况鉴定的,并且症状和标志完全消退。抗生素在非变应性鼻炎(NAR)儿童中预防RARS的角色还没有被调查。最近,有研究就阿奇霉素预防NAR儿童的RARS进行了评估。研究人员在患有RARS的NAR儿童(5-15岁)中设计了一个随机的、双盲的和安慰剂对照的研究。阿奇霉素(5 mg/kg/d) 3 d/wk共12个月和安慰剂分别分配到研究和对照组。排除

Clin Otolaryngol: 基于一个英国群体的关于鼻窦炎流行程度的调查

英国群体的鼻窦炎流行度所知信息有限。最近,有研究人员鉴定了其流行程度并且调查了任何与人口统计相关的变量。另外,研究人员还确定了病人的受损程度、对生活品质的影响和所有病人的花费。研究人员在一个小的但是成功的试样项目中利用了生活品质方式修正版本(MSNOT-20);鼻腔结果测试-20(SNOT-20)。然后,将其应用在基于群体的调查中,并在6个月后的第二阶段来测试其重复性。鼻腔检查和对生活品质的影响在

总结儿童鼻窦炎的三大特点

儿童正处在发育期,一些病症就趁着儿童发育未完全找来了。其中鼻窦化脓性病变就是其中一种。儿童鼻窦炎具有以下三大特点!